Keeping out of the kinase domain: Structure–activity relationship (SAR) studies of (Z)-3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione, a potent extracellular signal-related kinase-2 (ERK2) docking domain inhibitor

Kwan-young Jeong

Kerrick Nevels

Shilpa Worlikar

Jamal Chauhan

Sarice Smith

Jeremy Yap

Sagar Shukla

Joseph Slattery

Mary Ensey

Alexander Mackerell

Paul Shapiro

Steven Fletcher

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com